Authors:
Peng, HR
Chen, ST
Wergedal, JE
Polo, JM
Yee, JK
Lau, KHW
Baylink, DJ
Citation: Hr. Peng et al., Development of an MFG-based retroviral vector system for secretion of highlevels of functionally active human BMP4, MOL THER, 4(2), 2001, pp. 95-104
Citation: Hr. Peng et al., Cdc25A Protein phosphatase inhibitors from anomalous ozonolysis of 5,6-seco-5-oxo-3-cholesten-6-oic acid, TETRAHEDRON, 57(10), 2001, pp. 1891-1896
Authors:
Peng, HR
Xie, WG
Otterness, DM
Cogswell, JP
McConnell, RT
Carter, HL
Powis, G
Abraham, RT
Zalkow, LH
Citation: Hr. Peng et al., Syntheses and biological activities of a novel group of steroidal derived inhibitors for human CDC25A protein phosphatase, J MED CHEM, 44(5), 2001, pp. 834-848
Authors:
Xie, WG
Peng, HR
Zalkow, LH
Li, YH
Zhu, C
Powis, G
Kunkel, M
Citation: Wg. Xie et al., 3 beta-hydroxy-6-aza-cholestane and related analogues as phosphatidylinositol specific phospholipase C (PI-PLC) inhibitors with antitumor activity, BIO MED CH, 8(4), 2000, pp. 699-706
Citation: Hr. Peng et al., Interference between effector RNAs expressed from conventional dual-function anti-HIV retroviral vectors can be circumvented using dual-effector-cassette retroviral vectors, HUM GENE TH, 10(3), 1999, pp. 449-462
Citation: Hr. Peng et al., Novel CDC25A phosphatase inhibitors from pyrolysis of 3-alpha-azido-B-homo-6-oxa-4-cholesten-7-one on silica gel (vol 41, pg 4678, 1998), J MED CHEM, 42(9), 1999, pp. 1682-1682